Endocrine prevention of breast cancer

Russell E. McDaniel, V. Craig Jordan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Professor Antoine Lacassagne (1) stated a vision for the prevention of breast cancer at the annual meeting of the American Association of Cancer Research in Boston in 1936. “If one accepts the consideration of adenocarcinoma of the breast as the consequence of a special hereditary sensibility to the proliferative actions of oestrone, one is led to imagine a therapeutic preventative for subjects predisposed by their heredity to this cancer. It would consist - perhaps in the very near future when the knowledge and use of hormones will be better understood - in the suitable use of a hormone antagonistic or excretory, to prevent the stagnation of oestrone in the ducts of the breast.”.

Original languageEnglish (US)
Title of host publicationEarly Breast Cancer
Subtitle of host publicationFrom Screening to Multidisciplinary Management, Third Edition
PublisherCRC Press
Pages39-49
Number of pages11
ISBN (Electronic)9781841848860
ISBN (Print)9781841848853
DOIs
StatePublished - Jan 1 2013

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Endocrine prevention of breast cancer'. Together they form a unique fingerprint.

  • Cite this

    McDaniel, R. E., & Jordan, V. C. (2013). Endocrine prevention of breast cancer. In Early Breast Cancer: From Screening to Multidisciplinary Management, Third Edition (pp. 39-49). CRC Press. https://doi.org/10.1201/b13937